Crain’s Daily Gist: FDA blesses AbbVie’s new drug


—Credit: AbbVie

—Cutline: AbbVie’s North Chicago headquarters

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

The approval could help the North Chicago pharma firm replace revenue from its blockbuster Humira. Plus:Boeing suspends its forecast, McDonald’s turns up the pressure on Uber ahead of its IPO, Ford invests in electric truck maker Rivian, and more.

[protected-iframe id=”82753daa6ca090b0c4c2dedf940837a3-41642041-57574850″ info=”” width=”100%” height=”200px” scrolling=”no”]

More Home Page Top Stories